[METRIC]
A-A-53596A
13 November 1992
SUPERSEDING
A-A-0053596(DM)
12 August 1988
COMMERCIAL ITEM DESCRIPTION
BUMETANIDE INJECTION
The General Services Administration has authorized the use of this Commercial Item Description.
Salient characteristics.
Shall be Bumetanide Injection.
Materials used shall be of pharmaceutical grade.
Shall contain 0.25 mg Bumetanide per ml or injection within the applicable assay limits when assayed by a suitable accurate, and reproducible method.
Shall be suitable for intravenous or intramuscular use.
Workmanship. the injection shall be free from defects which detract from its appearance or impair its serviceability.
Unit. Package (PG). Shall be supplied 2 ml in a commercially available ampul. One package containing 10 ampuls, as specified, constitutes one unit.
Contractor certification. The contractor shall certify that the product offered meets the salient characteristics of this description and conforms to the producers’ own drawings, specifications, standards, and quality assurance practices. The Government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business